# Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

> **NCT02944734** · PHASE2 · COMPLETED · sponsor: **Shin Poong Pharmaceutical Co. Ltd.** · enrollment: 392 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Candesartan Cilexetil 8mg
- **DRUG:** Candesartan Cilexetil 16mg
- **DRUG:** Amlodipine 5mg
- **DRUG:** Amlodipine 10mg

## Key facts

- **NCT ID:** NCT02944734
- **Lead sponsor:** Shin Poong Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 392 (ACTUAL)
- **Last updated:** 2016-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02944734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02944734, "Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02944734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*